Clinical Study
Predictors of Developing Significant Mitral Regurgitation Following Percutaneous Mitral Commissurotomy with Inoue Balloon Technique
Table 1
Baseline Characteristics.
| Variable | Group A () | Group B () | P value |
| Clinical Characteristics: | (i) Age (Years) | | | 0.86 | (ii) Male/Females | 22/66 | 6/14 | 0.58 | (iii) Height | | | 0.81 | (iv) BSA | | | 0.92 | (v) Prior PMC | 13.6% | 15.8% | 0.95 | (vi) NYHA Class | | | 0.94 | (vii) AF | 27.2% | 31.6% | 0.59 |
| Pre-PMC Echo-Doppler data (except MV Scoring): | (i) MVA (cm2) | | | 0.37 | (ii) MG | | | 0.71 | (iii) SPAP | | | 0.67 | (iv) LA dimension | | | 0.47 |
|
|
BSA: body surface area; NYHA: New York Heart Association classification; AF: atrial fibrillation. *Significant at <0.05
|